Skip to main content

BASF sets out new strategy

30th September 2024

Submitted by:

Andrew Warmington

At its Capital Markets Day in Ludwigshafen, BASF presented a corporate strategy that, it said, “is setting a new direction”. ‘Winning Ways’ is set along four strategic levers of Focus, Accelerate, Transform and Win. “Our ambition is to be the preferred chemical company to enable our customers’ green transformation,” said Dr Markus Kamieth, chairman of the board of executive directors (pictured).

Focus involves redefining its approach to managing the portfolio, which differentiates between core businesses integrated into BASF’s value chains and the production verbund at major sites and standalone businesses that serve specific industries and compete with pure-play peers. In the former, mainly the Chemicals, Materials, Industrial Solutions and Nutrition & Care segments, BASF is among the top three global players in 75% of the businesses.

“We will capitalise on our market-leading positions in our core businesses through organic growth and disciplined, value-accretive acquisitions, while continuing our rigorous approach to pruning non-strategic or low-return businesses,” Kamieth said.

The standalone businesses will gain more strategic and operational flexibility to respond to the specific requirements of the markets they operate in. Thus, the company will continue to invest in them but “will also pursue active portfolio options where this adds value for BASF and its shareholders”.

Within the Coatings division, BASF will prepare a divestment process for the decorative paints business in Brazil. It will also complete the legal and ERP separation of the Agricultural Solutions business by 2027 and is looking towards a potential IPO. In the midterm, the listing of a minority share is an option.

The Environmental Catalyst & Metal Solutions and Battery Materials businesses will be reported as separate divisions in the Surface Technologies segment as of 1 January 2025. The company said that, in the light of recent market developments, it is “de-risking the path forward by focusing on filling existing capacities and exploring opportunities for collaborations along the value chain” for Battery Materials.

With Accelerate, BASF will aim at more speed in value generation and the simplification of its organisation. It will “empower its businesses through more streamlined and differentiated group steering”, making its operating divisions even more accountable for business success. Further initiatives include greater use of artificial intelligence to advance productivity and accelerate innovations.

Under Transform, BASF is taking initiatives to help customers achieve their green transformation targets. This has already begun by sourcing increasing amounts of renewable electricity and volumes of renewable feedstocks. To ramp up the latter, the company will set up a dedicated unit based on its approach for renewable energy.

Transformation-related spending is expected to average €600 million/year from 2025 to 2028. BASF confirmed its own climate protection targets and wish to make Ludwigshafen “a leading, sustainable chemical site for Europe and a strong pillar for BASF’s success”. This has already led to some asset adjustment measures, with the closure of the adipic acid, cyclododecanone and cyclopentanone plants being announced at the end of August. In addition, BASF will adjust its non-operations structures in Ludwigshafen and bring down costs through multiple measures.

With Win, finally, the company will “increase accountability, speed and performance orientation throughout the company”. BASF also plans to distribute at least €12 billion to shareholders from 2025 to 2028. This is underpinned by new financial targets of:

* EBITDA before special items of €10-12 billion in 2028 in mid to up-cycle conditions

* Cumulative free cash flow of over for €12 billion in 2025-2028

* Return on capital employed around 10% in 2028

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington